Insulin resistance, steatosis and hepatitis C virus View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-08-27

AUTHORS

Alessandra Mangia, Maria Ripoli

ABSTRACT

Epidemiological studies have shown an increased occurrence of metabolic disorders such as insulin resistance (IR) and steatosis in patients with hepatitis C virus (HCV) infection. IR is believed to represent one of the central clinical features of the "metabolic syndrome" and the major pathogenetic factor for type 2 diabetes mellitus. In patients with chronic HCV hepatitis, IR may have several dangerous consequences such as accelerated progression of liver fibrosis, resistance to antiviral therapy and development of hepatocellular carcinoma. According to recent evidence, the global epidemic of metabolic disorders related to incorrect diets will lead physicians to deal with 1.2 billion patients with diabetes in the world in 2025. Given the high prevalence of HCV infection in several countries, metabolic manifestations will contribute to increasing morbidity and mortality in patients with HCV chronic infection in the near future. HCV treatment, shown able to decrease both the occurrence of HCV-related IR and diabetes, may reduce the risk of the associated morbidities. More... »

PAGES

782-789

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12072-013-9460-1

DOI

http://dx.doi.org/10.1007/s12072-013-9460-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1049333085

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24587848


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Microbiology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Liver Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy", 
          "id": "http://www.grid.ac/institutes/grid.413503.0", 
          "name": [
            "Liver Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mangia", 
        "givenName": "Alessandra", 
        "id": "sg:person.01053502500.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053502500.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Liver Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy", 
          "id": "http://www.grid.ac/institutes/grid.413503.0", 
          "name": [
            "Liver Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ripoli", 
        "givenName": "Maria", 
        "id": "sg:person.01112470221.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112470221.60"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1111/j.1572-0241.2008.01813.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045989802", 
          "https://doi.org/10.1111/j.1572-0241.2008.01813.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2011.384", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006475526", 
          "https://doi.org/10.1038/ajg.2011.384"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2010.110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051174716", 
          "https://doi.org/10.1038/ajg.2010.110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.1998.00688.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012122130", 
          "https://doi.org/10.1111/j.1572-0241.1998.00688.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.2005.41403.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031505002", 
          "https://doi.org/10.1111/j.1572-0241.2005.41403.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10620-005-2788-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028207373", 
          "https://doi.org/10.1007/s10620-005-2788-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.2006.00835.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023893071", 
          "https://doi.org/10.1111/j.1572-0241.2006.00835.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00535-009-0133-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050338109", 
          "https://doi.org/10.1007/s00535-009-0133-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-08-27", 
    "datePublishedReg": "2013-08-27", 
    "description": "Epidemiological studies have shown an increased occurrence of metabolic disorders such as insulin resistance (IR) and steatosis in patients with hepatitis C virus (HCV) infection. IR is believed to represent one of the central clinical features of the \"metabolic syndrome\" and the major pathogenetic factor for type 2 diabetes mellitus. In patients with chronic HCV hepatitis, IR may have several dangerous consequences such as accelerated progression of liver fibrosis, resistance to antiviral therapy and development of hepatocellular carcinoma. According to recent evidence, the global epidemic of metabolic disorders related to incorrect diets will lead physicians to deal with 1.2 billion patients with diabetes in the world in 2025. Given the high prevalence of HCV infection in several countries, metabolic manifestations will contribute to increasing morbidity and mortality in patients with HCV chronic infection in the near future. HCV treatment, shown able to decrease both the occurrence of HCV-related IR and diabetes, may reduce the risk of the associated morbidities. ", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12072-013-9460-1", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1038556", 
        "issn": [
          "1936-0533", 
          "1936-0541"
        ], 
        "name": "Hepatology International", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "keywords": [
      "insulin resistance", 
      "metabolic disorders", 
      "hepatitis C virus infection", 
      "type 2 diabetes mellitus", 
      "chronic HCV hepatitis", 
      "occurrence of HCV", 
      "HCV chronic infection", 
      "major pathogenetic factor", 
      "hepatitis C virus", 
      "central clinical feature", 
      "HCV hepatitis", 
      "HCV infection", 
      "HCV treatment", 
      "clinical features", 
      "metabolic syndrome", 
      "diabetes mellitus", 
      "pathogenetic factor", 
      "antiviral therapy", 
      "accelerated progression", 
      "liver fibrosis", 
      "chronic infection", 
      "C virus", 
      "metabolic manifestations", 
      "virus infection", 
      "high prevalence", 
      "hepatocellular carcinoma", 
      "epidemiological studies", 
      "global epidemic", 
      "patients", 
      "incorrect diet", 
      "infection", 
      "increased occurrence", 
      "Recent evidence", 
      "morbidity", 
      "steatosis", 
      "diabetes", 
      "disorders", 
      "mellitus", 
      "HCV", 
      "hepatitis", 
      "carcinoma", 
      "fibrosis", 
      "syndrome", 
      "therapy", 
      "mortality", 
      "prevalence", 
      "physicians", 
      "progression", 
      "manifestations", 
      "epidemic", 
      "diet", 
      "virus", 
      "treatment", 
      "risk", 
      "resistance", 
      "occurrence", 
      "dangerous consequences", 
      "evidence", 
      "factors", 
      "near future", 
      "study", 
      "development", 
      "consequences", 
      "countries", 
      "features", 
      "future", 
      "world", 
      "C virus (HCV) infection"
    ], 
    "name": "Insulin resistance, steatosis and hepatitis C virus", 
    "pagination": "782-789", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1049333085"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12072-013-9460-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24587848"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12072-013-9460-1", 
      "https://app.dimensions.ai/details/publication/pub.1049333085"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:29", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_595.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12072-013-9460-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12072-013-9460-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12072-013-9460-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12072-013-9460-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12072-013-9460-1'


 

This table displays all metadata directly associated to this object as RDF triples.

173 TRIPLES      22 PREDICATES      103 URIs      86 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12072-013-9460-1 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 anzsrc-for:1108
4 schema:author Nadb996f2d8724656858fe940e621c5d2
5 schema:citation sg:pub.10.1007/s00535-009-0133-8
6 sg:pub.10.1007/s10620-005-2788-1
7 sg:pub.10.1038/ajg.2010.110
8 sg:pub.10.1038/ajg.2011.384
9 sg:pub.10.1111/j.1572-0241.1998.00688.x
10 sg:pub.10.1111/j.1572-0241.2005.41403.x
11 sg:pub.10.1111/j.1572-0241.2006.00835.x
12 sg:pub.10.1111/j.1572-0241.2008.01813.x
13 schema:datePublished 2013-08-27
14 schema:datePublishedReg 2013-08-27
15 schema:description Epidemiological studies have shown an increased occurrence of metabolic disorders such as insulin resistance (IR) and steatosis in patients with hepatitis C virus (HCV) infection. IR is believed to represent one of the central clinical features of the "metabolic syndrome" and the major pathogenetic factor for type 2 diabetes mellitus. In patients with chronic HCV hepatitis, IR may have several dangerous consequences such as accelerated progression of liver fibrosis, resistance to antiviral therapy and development of hepatocellular carcinoma. According to recent evidence, the global epidemic of metabolic disorders related to incorrect diets will lead physicians to deal with 1.2 billion patients with diabetes in the world in 2025. Given the high prevalence of HCV infection in several countries, metabolic manifestations will contribute to increasing morbidity and mortality in patients with HCV chronic infection in the near future. HCV treatment, shown able to decrease both the occurrence of HCV-related IR and diabetes, may reduce the risk of the associated morbidities.
16 schema:genre article
17 schema:inLanguage en
18 schema:isAccessibleForFree true
19 schema:isPartOf N35a9436b200c442cb264b323deb5ef0b
20 N97e0ac53b57f48a3b8a38d992037ce04
21 sg:journal.1038556
22 schema:keywords C virus
23 C virus (HCV) infection
24 HCV
25 HCV chronic infection
26 HCV hepatitis
27 HCV infection
28 HCV treatment
29 Recent evidence
30 accelerated progression
31 antiviral therapy
32 carcinoma
33 central clinical feature
34 chronic HCV hepatitis
35 chronic infection
36 clinical features
37 consequences
38 countries
39 dangerous consequences
40 development
41 diabetes
42 diabetes mellitus
43 diet
44 disorders
45 epidemic
46 epidemiological studies
47 evidence
48 factors
49 features
50 fibrosis
51 future
52 global epidemic
53 hepatitis
54 hepatitis C virus
55 hepatitis C virus infection
56 hepatocellular carcinoma
57 high prevalence
58 incorrect diet
59 increased occurrence
60 infection
61 insulin resistance
62 liver fibrosis
63 major pathogenetic factor
64 manifestations
65 mellitus
66 metabolic disorders
67 metabolic manifestations
68 metabolic syndrome
69 morbidity
70 mortality
71 near future
72 occurrence
73 occurrence of HCV
74 pathogenetic factor
75 patients
76 physicians
77 prevalence
78 progression
79 resistance
80 risk
81 steatosis
82 study
83 syndrome
84 therapy
85 treatment
86 type 2 diabetes mellitus
87 virus
88 virus infection
89 world
90 schema:name Insulin resistance, steatosis and hepatitis C virus
91 schema:pagination 782-789
92 schema:productId N7397b9c853964c43a046f6710cd9600c
93 Na95eb1cc0b174bd3a5c9552938806b8e
94 Ne46fce05ef284b298063eb69c75aa5b3
95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049333085
96 https://doi.org/10.1007/s12072-013-9460-1
97 schema:sdDatePublished 2022-01-01T18:29
98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
99 schema:sdPublisher Nb1683ec517944b02a5caf01b43aaf147
100 schema:url https://doi.org/10.1007/s12072-013-9460-1
101 sgo:license sg:explorer/license/
102 sgo:sdDataset articles
103 rdf:type schema:ScholarlyArticle
104 N2463cfa7148d410a9799a0bfdf5548f7 rdf:first sg:person.01112470221.60
105 rdf:rest rdf:nil
106 N35a9436b200c442cb264b323deb5ef0b schema:issueNumber Suppl 2
107 rdf:type schema:PublicationIssue
108 N7397b9c853964c43a046f6710cd9600c schema:name doi
109 schema:value 10.1007/s12072-013-9460-1
110 rdf:type schema:PropertyValue
111 N97e0ac53b57f48a3b8a38d992037ce04 schema:volumeNumber 7
112 rdf:type schema:PublicationVolume
113 Na95eb1cc0b174bd3a5c9552938806b8e schema:name dimensions_id
114 schema:value pub.1049333085
115 rdf:type schema:PropertyValue
116 Nadb996f2d8724656858fe940e621c5d2 rdf:first sg:person.01053502500.23
117 rdf:rest N2463cfa7148d410a9799a0bfdf5548f7
118 Nb1683ec517944b02a5caf01b43aaf147 schema:name Springer Nature - SN SciGraph project
119 rdf:type schema:Organization
120 Ne46fce05ef284b298063eb69c75aa5b3 schema:name pubmed_id
121 schema:value 24587848
122 rdf:type schema:PropertyValue
123 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
124 schema:name Medical and Health Sciences
125 rdf:type schema:DefinedTerm
126 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
127 schema:name Clinical Sciences
128 rdf:type schema:DefinedTerm
129 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
130 schema:name Medical Microbiology
131 rdf:type schema:DefinedTerm
132 sg:journal.1038556 schema:issn 1936-0533
133 1936-0541
134 schema:name Hepatology International
135 schema:publisher Springer Nature
136 rdf:type schema:Periodical
137 sg:person.01053502500.23 schema:affiliation grid-institutes:grid.413503.0
138 schema:familyName Mangia
139 schema:givenName Alessandra
140 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053502500.23
141 rdf:type schema:Person
142 sg:person.01112470221.60 schema:affiliation grid-institutes:grid.413503.0
143 schema:familyName Ripoli
144 schema:givenName Maria
145 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112470221.60
146 rdf:type schema:Person
147 sg:pub.10.1007/s00535-009-0133-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050338109
148 https://doi.org/10.1007/s00535-009-0133-8
149 rdf:type schema:CreativeWork
150 sg:pub.10.1007/s10620-005-2788-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028207373
151 https://doi.org/10.1007/s10620-005-2788-1
152 rdf:type schema:CreativeWork
153 sg:pub.10.1038/ajg.2010.110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051174716
154 https://doi.org/10.1038/ajg.2010.110
155 rdf:type schema:CreativeWork
156 sg:pub.10.1038/ajg.2011.384 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006475526
157 https://doi.org/10.1038/ajg.2011.384
158 rdf:type schema:CreativeWork
159 sg:pub.10.1111/j.1572-0241.1998.00688.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1012122130
160 https://doi.org/10.1111/j.1572-0241.1998.00688.x
161 rdf:type schema:CreativeWork
162 sg:pub.10.1111/j.1572-0241.2005.41403.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1031505002
163 https://doi.org/10.1111/j.1572-0241.2005.41403.x
164 rdf:type schema:CreativeWork
165 sg:pub.10.1111/j.1572-0241.2006.00835.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1023893071
166 https://doi.org/10.1111/j.1572-0241.2006.00835.x
167 rdf:type schema:CreativeWork
168 sg:pub.10.1111/j.1572-0241.2008.01813.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1045989802
169 https://doi.org/10.1111/j.1572-0241.2008.01813.x
170 rdf:type schema:CreativeWork
171 grid-institutes:grid.413503.0 schema:alternateName Liver Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
172 schema:name Liver Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
173 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...